#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15666	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2353	663.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1591	1591	C	896	C	835	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	0	.	n	.	0	A20C	SNP	20	20	A	351	351	C	471	C,A	449,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	0	.	n	.	0	T695C	SNP	695	695	T	1026	1026	C	844	C,T	802,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1969	1969	G	879	G,A	826,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2302	2302	C	906	C,A	843,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2376	2376	A	884	A	840	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27606	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3627	759.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2928	2928	C	876	C	822	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	6	blaTEM	861	177	100.0	blaTEM.l15.c4.ctg.1	177	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2128	folP	855	855	100.0	folP.l6.c30.ctg.1	1553	136.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1042	1044	AGC	238;237;235	A,G;G;C	221,1;221;219	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3318	164.8	1	SNP	p	S91F	1	.	.	271	273	TTC	539	541	TTC	171;170;172	T;T;C	160;161;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3318	164.8	1	SNP	p	D95G	1	.	.	283	285	GGC	551	553	GGC	160;159;160	G;G;C	150;148;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3318	164.8	1	SNP	p	G95N	0	.	.	283	285	GGC	551	553	GGC	160;159;160	G;G;C	150;148;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1738	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1389	124.8	0	.	p	.	0	F184L	NONSYN	550	552	TTC	905	907	TTG	217;217;216	T;T;G	201;201;195	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1738	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1389	124.8	1	SNP	p	G45D	0	.	.	133	135	GGC	488	490	GGC	229;230;230	G;G;C	215;214;214	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	818	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1012	80.3	0	.	n	.	0	A197.	DEL	197	197	A	536	536	A	177	A	172	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	165.7	1	SNP	p	D86N	0	.	.	256	258	GAC	567	569	GAC	185;190;190	G;A;C	175;174;181	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	165.7	1	SNP	p	R87W	0	.	.	259	261	CGT	570	572	CGT	191;190;190	C,T;G;T	180,1;177;175	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	165.7	1	SNP	p	S87R	1	.	.	259	261	CGT	570	572	CGT	191;190;190	C,T;G;T	180,1;177;175	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	165.7	1	SNP	p	R87I	0	.	.	259	261	CGT	570	572	CGT	191;190;190	C,T;G;T	180,1;177;175	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5082	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	165.7	1	SNP	p	S88P	0	.	.	262	264	TCC	573	575	TCC	191;196;199	T;C;C	178;184;188	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4470	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2506	177.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	231;231;230	G;G;C,T	218;214;214,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1194	1196	GCA	224;224;225	G;C;A	205;205;207	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1197	1199	ATC	227;228;233	A,G;T;C	209,1;211;211	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1209	1211	GTG	229;230;230	G;T;G	214;214;215	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1209	1211	GTG	229;230;230	G;T;G	214;214;215	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1713	1715	ACC	237;238;236	A;C;C	212;213;217	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1767	1769	GCG	230;229;230	G;C,A;G	199;178,1;189	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1767	1769	GCG	230;229;230	G;C,A;G	199;178,1;189	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1890	1892	AGC	205;200;198	A;G;C	195;190;188	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1899	1901	GGC	188;188;186	G;G;C	180;178;175	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4218	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2337	179.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1917	1919	CCG	158;163;166	C,G;C;G	110,9;115;123	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5948	ponA	2397	2397	99.92	ponA.l15.c30.ctg.1	3190	186.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2336	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1894	122.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	578	578	C	187	C	168	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	361	363	GAA	213;213;209	G;A;A	199;199;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	K120N	NONSYN	358	360	AAG	607	609	AAT	220;221;222	A;A;T	208;207;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	772	774	TCA	236;238;238	T;C;A	221;221;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	901	903	GTC	229;228;228	G;T;C	219;216;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	P219T	NONSYN	655	657	CCT	904	906	ACC	224;223;226	A;C;C	212;214;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	913	915	TCT	231;230;231	T;C;T	217;219;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1231	1233	GCA	259;263;264	G;C;A	244;247;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	1	SNP	p	D121N	0	.	.	361	363	GAC	610	612	GAC	223;221;222	G;A;C	208;206;210	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2896	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1415	201.0	1	SNP	p	A121D	1	.	.	361	363	GAC	610	612	GAC	223;221;222	G;A;C	208;206;210	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10944	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4763	229.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1296	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	937	136.9	1	SNP	p	V57M	1	.	.	169	171	ATG	473	475	ATG	268;270;273	A;T;G	256;257;258	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
